Detalhe da pesquisa
1.
hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy.
Brief Bioinform
; 23(2)2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037026
2.
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.
Ann Hematol
; 102(4): 897-906, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856803
3.
Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.
J Surg Oncol
; 128(5): 844-850, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341164
4.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
5.
Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study.
Future Oncol
; 15(28): 3197-3208, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512500
6.
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.
Future Oncol
; 15(28): 3189-3196, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512497
7.
Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia.
Support Care Cancer
; 27(8): 2877-2884, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30554278
8.
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Lancet Oncol
; 18(6): 770-778, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495639
9.
Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia.
Blood
; 136(23): 2715-2719, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698198
10.
Mouse models of human AML accurately predict chemotherapy response.
Genes Dev
; 23(7): 877-89, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19339691
11.
The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.
Future Oncol
; 12(17): 2009-20, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27279153
12.
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
Blood
; 121(21): 4287-94, 2013 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23550038
13.
Animal models of leukemia: any closer to the real thing?
Cancer Metastasis Rev
; 32(1-2): 63-76, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23081702
14.
Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.
Blood
; 119(15): 3561-70, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22362039
15.
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
Ann Hematol
; 93(1): 47-55, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149914
16.
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
Leuk Lymphoma
; : 1-11, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712673
17.
Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia.
Cancers (Basel)
; 15(2)2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672433
18.
Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia.
J Geriatr Oncol
; 14(7): 101509, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454532
19.
Adenosine Monophosphate Activated Protein Kinase (AMPK) enhances chemotherapy response in Acute Myeloid Leukemia (AML).
Cancer Lett
; 535: 215659, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321842
20.
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.
Nat Commun
; 13(1): 1673, 2022 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354808